Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Stephen Gandel
Stay informed with Stephen Gandel’s coverage and analysis for Coins2Day.
Page 23 of 78
Finance
Here’s Why Valeant CEO Michael Pearson’s Stock Sale Matters
By
Contributing Writer
Finance
Jamie Dimon: Don’t be so Damned Depressed
By
Investment Desk
Finance
Jamie Dimon: Virtual Currency Will Be Stopped
By
Investment Desk
Finance
What Bank Accounts and Toilets Can Teach Us About Corruption in India
By
Financial Writer
Finance
Bond Market Rally: It’s Not Time for Economic Celebration Just Yet
By
Editorial Team
Finance
Chart: Here’s what the U.S.’s largest companies are doing with their cash
By
Industry Analyst
Health
Valeant: A timeline of the big Pharma scandal
By
Trading Desk
Finance
Bill Ackman on Valeant: ‘Life will go on’
By
Investment Desk
Finance
Pfizer-Allergan could be a super inversion deal
By
Research Team
Finance
Valeant accounting scandal: 4 critical questions that have been left unanswered
By
News Correspondent
Finance
What the drop in Valeant’s stock says about hedge funds’ herd mentality
By
Industry Analyst
Finance
Valeant short seller on pharmacy alliance: It’s the ‘turd in the punch bowl’
By
Digital Assets Editor
Finance
Valeant’s accounting problems: It gets worse
By
Blockchain Reporter
Finance
Warren Buffett’s really bad week
By
Contributing Writer
Finance
What the $5 billion Stuyvesant Town deal says about the real estate market
By
Market Analyst